Reducing respiratory infections in primary care: the Immune Defence Study

niversity of Southampton0 个研究点目标入组 13,799 人开始时间: 2020年10月30日最近更新: 2024年7月29日

适应症

试验速览

2023 Protocol article in https://pubmed.ncbi.nlm.nih.gov/37450460/ (added 17/07/2023) 2024 Results article in https://pubmed.ncbi.nlm.nih.gov/39004091/ (added 16/07/2024)

•1. Patients aged =18 years with a risk factor:
•1.1. Known weakened immune system due to a serious illness or medication (e.g. chemotherapy)
•1.2. Known heart disease
•1.3. Known asthma or lung disease
•1.4. Known diabetes
•1.5. Known mild hepatic impairment
•1.6. Known stroke or neurological problem
•1.7. Obesity (BMI >30)
•1.8. Patients with =3 episodes of an RTI in the last year
•2. Patients aged =65
•3. Have access to the internet

•1. Terminal illness/palliative care
•2. Living with dementia
•3. Living in residential care
•4. Pregnancy or breastfeeding
•5. Regular use of nasal sprays for respiratory infection control in the last 6 months
•6. Allergy to nasal sprays
•7. Living in the same household as another participant
•8. Previously involved in RECUR programme development work

发起方

niversity of Southampton